The call ran from 10:01 AM to 10:48 AM IST (47 min).
Key takeaways
Q2 revenue ₹511 Cr (+25%), H1 ₹987 Cr (+22%); margins compressed by new-hospital losses and higher consumable costs.
| Revenue growth | Q2 +25% YoY to ₹511 Cr; H1 +22% to ₹987 Cr. |
|---|---|
| Margins | H1 EBITDA margin 23.1%; Q2 19.9%; new hospitals drag; established 26%. |
| Demand visibility | Q2 IPD +31%, OPD +29% YoY; occupancy 56% vs 68%. |
| Management confidence | Confident; calls price-capping impact negligible, quantifies CGHS hit. |
Growth
Q2 revenue +25% YoY to ₹511 Cr; new hospitals at -8% EBITDA; 14 established hospitals at 26%.
Outlook
FY27 revenue ~₹2,050 Cr guided; 2,300 beds by Dec 2028 at ~₹750 Cr capex.
Risks
Occupancy 56% vs 68% last year; sharp gross-margin contraction; receivable days ~136; CGHS rate-cut drag ~₹60 Cr.
Summary by ALFA Finder, written with AI assistance from our own recording of the call, published . Open it on ALFA Filings ›
The results behind this call
Park Medi World Q2 FY27 Results: Net Profit ₹54.5 Cr, Down 30.7% YoY
Park Medi World Ltd reported revenue from operations of ₹511 Cr (+24.6% YoY) and net profit of ₹54.5 Cr (-30.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹54.5 Cr · -30.7% YoY
What management said last time
Full summary →From the call summary published .
Outlook they gave
Targeting 5,460 beds by FY28 via ₹500cr capex; aiming for 10,000+ beds by FY33.
Growth they described
FY26 Revenue grew 21% to ₹1,679cr; EBITDA rose 20% to ₹444cr; PAT increased 27% to ₹274cr.
Call details
| Company | Park Medi World Ltd |
|---|---|
| NSE symbol | PARKHOSPS |
| ISIN | INE119201023 |
| Call | Q2 FY27 earnings call |
| Date | Saturday, 14 November 2026 |
| Time | 10:00 AM IST |
| Length | 47 min |
| Audio | Our stream on YouTube ↗ |
Park Medi World Ltd: key numbers
- Share price
- ₹238.05
- Market cap
- ₹10,282 Cr
- Revenue (annual)
- ₹1,679 Cr
- Net profit (annual)
- ₹258.1 Cr
- P/E (TTM)
- 40.1×Sector 64.9×
- Promoter holding
- 82.90%+0.01% QoQ
- FII holding
- 0.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.